Mireia Melé

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

Sibylle Loibl, Frederik Marmé, Miguel Martín et al. · Journal of Clinical Oncology · 2021 · 324 citations

Medicine, Oncology, Pharmacology +17

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial

Eva Ciruelos, Patricia Villagrasa, Tomás Pascual et al. · Clinical Cancer Research · 2020 · 113 citations

Medicine, Oncology, Pharmacology +17

Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study

Miguel Gil‐Gil, Meritxell Bellet, Serafín Morales et al. · Breast Cancer Research and Treatment · 2015 · 52 citations

Medicine, Oncology, Pharmacology +17

Fatal pneumonitis induced by oxaliplatin

Sara Arévalo Lobera, Naiara Sagastibeltza Mariñelarena, Ibone Elejoste Echeberría et al. · Clinical & Translational Oncology · 2008 · 28 citations

Medicine, Internal Medicine, Oncology +9